EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt
· Delayed Price · Currency is EGP 101.06
+2.17 (2.19%)
At close: Mar 8, 2026
EGX:NIPH Revenue
EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of 598.46M EGP in the quarter ending December 31, 2025, with 26.20% growth. This brings the company's revenue in the last twelve months to 1.97B, up 103.03% year-over-year. In the fiscal year ending June 30, 2025, EI- Nile Co. for Pharmaceuticals and Chemical Industries had annual revenue of 1.29B with 12.86% growth.
Revenue (ttm)
1.97B
Revenue Growth
+103.03%
P/S Ratio
2.56
Revenue / Employee
789.30K
Employees
2,500
Market Cap
5.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.29B | 146.99M | 12.86% |
| Jun 30, 2024 | 1.14B | 137.37M | 13.67% |
| Jun 30, 2023 | 1.01B | 128.44M | 14.65% |
| Jun 30, 2022 | 876.78M | 121.27M | 16.05% |
| Jun 30, 2021 | 755.51M | -57.02M | -7.02% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition